Status:
COMPLETED
Effectiveness of Periodontal Therapy on Periodontal Bacteria
Lead Sponsor:
University of Catania
Conditions:
Periodontitis
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
In light of the controversy that are already approved but that however still exists regarding the efficacy and influence of the protocols for the management of Periodontitis, the aim of this study was...
Detailed Description
This trial was conducted in accordance with the World Medical Association's Declaration of Helsinki of 1975, and reviewed in 2008. The local ethical committee of the University of Messina approved the...
Eligibility Criteria
Inclusion
- Presence of at least 15 teeth
- CP with a minimum of 40% of sites with a clinical attachment level (CAL)
- ≥2mm and probing depth (PD) ≥4mm;
- Presence of at least ≥2 mm of crestal alveolar bone loss verified on digital periapical radiographs
- Presence of ≥40% sites with bleeding on probing (BOP)
Exclusion
- Intake of contraceptives
- Intake of immunosuppressive or anti-inflammatory drugs throughout the last three months prior to the study
- Status of pregnancy or lactation
- Previous history of excessive drinking
- Allergy to local anaesthetic
- Intake of drugs that may potentially determine gingival hyperplasia such as Hydantoin, Nifedipine, Cyclosporin A or similar drugs.
Key Trial Info
Start Date :
February 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2022
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04735692
Start Date
February 5 2021
End Date
December 5 2022
Last Update
December 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Catania
Catania, CT, Italy, 95124